The Recall Desk
HighFDA (Drugs)·D-0444-2025·Announced 2025-05-28

[pending] AIRSUPRA (ALBUTEROL SULFATE AND BUDESONIDE)

Pending LLM rewrite. Source: FDA_DRUG D-0444-2025.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Pending LLM scoring against the rubric.

Plain-English summary

Defective delivery system

The recalled product

Product
AIRSUPRA (ALBUTEROL SULFATE AND BUDESONIDE)
Brand
AIRSUPRA
Manufacturer
AsttraZeneca Pharmaceuticals LP
Category
Drug — Drugs

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (20)

  • Lot#: a) 6270044C00
  • 6270040D00
  • 6270034E00
  • Exp Date 10/2026
  • 6270053C00
  • 6270045C00
  • 6270047C00
  • 6270056C00
  • 6270052C00
  • 6270063E00 Exp 11/30/2026
  • 6270064C00
  • 6270071D00
  • 6270075D00
  • 6270075F00 Exp Date 12/31/2026
  • 6270107C00
  • Exp Date 9/30/2027
  • b) Lot 6270019E00
  • Exp Date 7/31/2025
  • 6270021D00
  • Exp 8/31/2025

Distribution

Distributed nationwide across the United States.

Related recalls

Same category